Annual Drug Patent Expirations for LAMICTAL+ODT Lamictal Odt is a drug marketed by Glaxosmithkline Llc and is included in one NDA. It is available from one supplier. There are three…
The post New patent for Glaxosmithkline Llc drug LAMICTAL ODT appeare…
New patent for Glaxosmithkline Llc drug LAMICTAL ODT Read Post »
AFINITOR (everolimus) Novartis Patent: 8,778,962 Expiration: Aug 18, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug Pa…
Drug Patent Expirations for the Week of August 14, 2022 Read Post »
Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Therap Us and is included in one NDA. There are forty-one patents protecting this drug. This drug…
The post New patent for Amicus Therap drug GALAFOLD appeared first on D…
This chart shows the drugs with the most patents in France. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in France? …
Which pharmaceutical drugs have the most drug patents in France? Read Post »
Annual Drug Patent Expirations for XALKORI Xalkori is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Pf Prism drug XALKORI appeared first on DrugPatentWatch – Make B…
Annual Drug Patent Expirations for IMBRUVICA Imbruvica is a drug marketed by Pharmacyclics Inc and is included in two NDAs. It is available from one supplier. There are forty patents…
The post New patent for Pharmacyclics Inc drug IMBRUVICA appeared fi…
Annual Drug Patent Expirations for WAKIX Wakix is a drug marketed by Harmony and is included in one NDA. There are three patents protecting this drug. This drug has fifty-three…
The post New patent for Harmony drug WAKIX appeared first on DrugPatentWat…
Annual Drug Patent Expirations for KINEVAC Kinevac is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent expiration for Bracco drug KINEVAC appeared first on Drug…
Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent for Eisai Inc drug HALAVEN appeared first on DrugPatentWatch -…
This chart shows the drugs with the most patents in Portugal. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Portug…
Which pharmaceutical drugs have the most drug patents in Portugal? Read Post »
Get new actionable insights and updates from BiotechBlog
